Haemonetics (HAE) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $83.60 -2.08%
EPS Growth %: -0.9%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
GLXY, CRVL, SGHC, More
EPS Growth %: -0.9%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
GLXY, CRVL, SGHC, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.25, $0.03 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $210 million versus the consensus estimate of $205.41 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paysign, Inc. (PAYS) Tops Q2 EPS by 5c ; Offers Guidance
- Innoviva (INVA) Misses Q2 EPS by 157c
- AMERCO (UHAL) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
